User access denied after system block

Medicare’s 2.5% dermatology reimbursement increase for 2026 falls short, leaving clinics struggling with rising costs and denied user…

Dermatologists use advanced atopic dermatitis treatments but lack predictive biomarkers for precise therapy selection.

Using insulin pump with Control-IQ technology improves glycemic status in type 2 diabetes patients with multiple daily injections,…

Health plans are blocking users from content. Learn how new Medicare changes impact formulary access and patient care.

HIV/AIDS relief efforts disrupted, affecting vulnerable populations with HIV infection, according to PEPFAR findings and survey results.

Cancer mortality rates gap between Black and White individuals narrowed since 1990s, driven by lung and prostate cancer…

Step therapy for Vabysmo leads to treatment delays and higher costs for patients and eye‑care providers, highlighting the…

Patients with eye disease face worsening conditions after losing access to copay assistance for anti-VEGF drugs, study reveals.

Medicaid reimbursement rates vary widely across states, affecting patient care and vitreoretinal procedures, including vitrectomy and retinal detachment…

FDA approves Merck's Lipfendra to reduce LDL cholesterol in adults with hypercholesterolemia using PCSK9 inhibitor.